Companies / Pulse Biosciences, Inc.
Pulse Biosciences, Inc.
Nasdaq: PLSECIK 1625101HAYWARD, CA
Financials · FY2025
Ownership
71.3M shares outstanding · as of Jul 31, 2026
Ownership
| Insiders | 67.68% | 48,269,731 |
| Institutions | 10.22% | 7,287,809 |
| Public float | 22.10% | 15,765,067 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 5
View all →| Insider | % of shares | Shares |
|---|---|---|
Robert W. DugganDirector · 10% owner | 67.60% | 48,211,433 |
Danahy Kevin PatrickChief Commercial Officer | 0.06% | 43,298 |
Laviolette Paul aCEOChief Executive Officer · Director | 0.02% | 15,000 |
Sainz MariaFormerDirector | — | — |
Uecker DarrinChief Technology Officer · Director | — | — |
Institutional holders 89
View all →| Holder | Value | % of shares |
|---|---|---|
| $40.67M | 2.06% | |
| $15.83M | 1.03% | |
| $15.36M | 1.57% | |
| $14.69M | 0.74% | |
| $10.99M | 1.12% | |
| $10.62M | 0.69% | |
| $5.72M | 0.37% | |
| $3.11M | 0.32% | |
| $2.53M | 0.26% | |
| $2.09M | 0.21% |
Activity
Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q1 2026 as of | Portolan Capital Management, LLC 13F manager | Add | Common Stock | $7.34M | +340K +86.37% | 733,372 1.03% of shares | medium |
| Q1 2026 as of | Balyasny Asset Management L.P. 13F manager | New | Common Stock | $5.72M | +265K | 265,164 0.37% of shares | medium |
| Q2 2026 as of | BlackRock, Inc. 13F manager | Add | Common Stock | $3.04M | +110K +8.08% | 1,466,702 2.06% of shares | low |
| Q2 2026 as of | State Street Corporation 13F manager | Add | Common Stock | $2.29M | +83K +18.47% | 529,624 0.74% of shares | low |
| Q1 2026 as of | Millennium Management LLC 13F manager | New | Common Stock | $1.21M | +56K | 55,817 0.08% of shares | low |
| Q1 2026 as of | Formula Growth Ltd 13F manager | New | Common Stock | $647.7K | +30K | 30,000 0.04% of shares | low |
| Q1 2026 as of | Geode Capital Management, LLC 13F manager | Add | Common Stock | $590.2K | +27K +5.88% | 491,946 0.69% of shares | low |
| Q3 2024 as of | Barclays PLC 13F manager | Add | Common Stock | $416.4K | +24K +361.42% | 30,306 0.04% of shares | low |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| PLSE | Common Stock | 74587B101 |